Q1 2017 Titan Pharmaceuticals Inc Earnings Call

10/5/2017 16:15

Conference Call Titan Pharmaceuticals Inc

Titan Pharmaceuticals Inc Conference call or earnings call will be held on May 10, 2017
During the earnings conference call’s session, Titan Pharmaceuticals Inc will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact Titan Pharmaceuticals Inc for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
We are a specialty pharmaceutical company developing proprietary therapeutics for the treatment of serious medical disorders. Our product development programs utilize our proprietary long-term drug delivery platform, ProNeura®, and focus primarily on innovative treatments for select chronic diseases for which steady state delivery of a drug provides an efficacy and/or safety benefit. All share and per share amounts give retroactive effect to a 1 for 5.5 reverse stock split effected in September 2015. Probuphine®, our first product candidate to utilize ProNeura, is being developed for the long term maintenance treatment of opioid dependence and is designed to maintain a stable, around the clock blood level of the medicine buprenorphine in patients for six months following a single treatment. We have licensed the rights to commercialize Probuphine in the U.S. and Canada to Braeburn Pharmaceuticals, Inc.    
Read more Conference Call

Titan Pharmaceuticals Inc (TTNP)

400 Oyster Point Boulevard, South San Francisco California 94080, United States